Apollo Therapeutics partners with Oxford University to accelerate drug discovery and development.

Apollo Therapeutics partners with the University of Oxford to accelerate drug discovery and development, leveraging Oxford's biomedical research. Apollo will identify and assess therapeutic targets for new medicines, enhancing access to clinical trials and speeding market introduction. This collaboration is Apollo's sixth with a university or research center, aiming to transform research discoveries into valuable new drugs.

July 21, 2024
6 Articles

Further Reading